Our Board of Advisors, all industry leaders, have made a powerful statement by supporting Life Science Cares and our goal to end poverty in our community. Our Advisors make a personal financial contribution annually to cover LSC’s administrative costs, allowing us to channel money raised from our events, Corporate Membership contributions, and donations from other individuals to our partner organizations.
Our Board of Advisor members also choose to volunteer with their companies and recruit their colleagues to join in this collective effort.
BOSTON BOARD OF ADVISORS
ABCDEFGHIJKLMNOPQRSTUVWXYZ
Jeff Albers
CEO – Blueprint Medicines
Rich Aldrich
General Partner – Longwood Fund
Pat Andrews
CEO – Sumitomo Dainippon Pharma Oncology
Tom Andrews
Executive Vice President – Alexandria Real Estate Equities, Inc.
Imran Babar
Chief Business Officer – Cydan II Inc.
Mark Bamforth
President & CEO – Arranta Bio
Stephane Bancel
CEO – Moderna Therapeutics
Peter Barrett
Partner – Atlas Venture
Russell Bartlett
Vice President – Alex BrownMarc Beer
CEO – Renovia
Kevin Bitterman
Partner – Atlas Venture
Mitch Bloom
Partner – Goodwin
Joshua Boger
Foundation & CEO (Former) – Vertex Pharmaceuticals
Mike Bonney
Executive Chair – Kaleido Biosciences
Bruce Booth
Partner – Atlas Venture
Katrine Bosley
Chairman of the Board – Arrakis Therapeutics
Michael Broxson
CEO – Q32 Bio
Gerry Brunk
Managing Director – Lumira VC
Paul Burgess
Chief Legal Officer & Chief Operating Officer – Translate BioStuart Cable
Partner – Goodwin
Pablo Cagnoni
CEO – Rubius Therapeutics
Thomas Carey
Founder & Managing Partner – Perspective Group
Abe Ceesay
CEO – Tiburio TherapeuticsAbbie Celniker
Partner – Third Rock Ventures
Scott Chamberlin
Senior Vice President & Head of Innovation Banking – Cambridge Trust
Bharatt Chowrira
President – PureTech Health
Tim Clackson
President & Chief Technology Officer – Xilio Therapeutics
Paul Clancy
Executive Vice President (Former) – AlexionChip Clark
President & CEO – Genocea
Hugh Cole
Chief Business Officer & Head of Corporate Development – Jounce Therapeutics
Tony Coles
CEO – Cerevel Therapeutics
Ron Cooper
President & CEO – Albireo PharmaBob Coughlin
President & CEO – MassBio
Zoltan Csimma
Senior Biotech Executive
Zoltan Csimma
Senior Biotech Executive
Elisabet De los Pinos
CEO – Aura Biosciences
Dee Dee DeMan
Chairman & CEO – Bench International
Tom DesRosier
Executive Vice President & Chief Legal Officer – Seres Therapeutics
Steven Dickman
Owner – CBT AdvisorsMichelle Dipp
Co-Founder and Managing Partner – Biospring PartnersEd Downey
Principal – Plimouth Rock Risk ConsultingNeal Dunn
Partner – Trinity
Tim Ehrlich
Partner – Gunderson Dettmer Stough Villeneuve FranklinPaul Enderle
Managing Director – Baycross Capital Group
Wendy Erler
VP, Head of STAR Patient Insights & Advocacy
Wendy Erler
VP, Head of STAR Patient Insights & Advocacy
Greg Erman
CEO – EmpiraMedElan Ezickson
Founding CEO – Sporos BioventuresDouglas Fambrough
CEO – Dicerna
Joe Farmer
Chief Operating Officer – Xilio Therapeutics
Ali Fattaey
CEO – MetaboMedRobert Forrester
Co-Founder & CXO – EQRx
James Foster
Chairman, President & CEO – Charles River Labs
Chris Gabrieli
Biotech VC (Retired)
Chris Gabrieli
Biotech VC (Retired)Nick Galakatos
Senior Managing Director – BlackstoneDaniel Geffken
Managing Director – Danforth Advisors
Jean George
General Partner – Lightstone VenturesJim Geraghty
Experienced Board Director & Chair
Jim Geraghty
Experienced Board Director & ChairHalley Gilbert
Chief Operating Officer & Chief Business Officer – Adagio Therapeutics
Glen Giovannetti
Global Biotechnology Leader (Retired) – EYJohn Glasspool
CEO – Anthos Therapeutics
Jeff Goater
CEO – Surface Oncology
Brian Goff
Chief Commercial and Global Operations Officer – AlexionKurt Graves
Chairman, President & CEO – Intarcia
Mike Gray
Chief Financial & Chief Operating Officer – Imara Therapeutics
Dave Grayzel
Partner – Atlas Venture
Adam Gridley
CEO – Foundry Therapeutics 1
Chris Guiffre
Chief Financial & Chief Operating Officer – Pear Therapeutics
Penny Heaton
CEO – Bill & Melinda Gates Medical Research Institute
Michael Heffernan
Chairman – Collegium Pharmaceuticals
Bill Heiden
Healthcare Executive & Board Member
Bill Heiden
Healthcare Executive & Board Member
Jeffrey Hemman
Partner – PWCBill Hicks
Partner – Mintz
Donna Higgins
President & CEO – The Higgins GroupColin Hill
CEO, Chairman & Co-Founder – GNS HealthcareAndrew Hirsch
CEO – C4 TherapeuticsRoy Hirshland
CEO & Co-Founder – T3 Advisors
Maura Hodge
Partner – KPMGSteve Holtzman
Tim Hunt
Senior Vice President, Corporate Affairs (Former) – Editas Medicine
Trish Hurter
CEO & President – Lyndra Therapeutics
Doug Ingram
CEO – Sarepta
Bruce Jacobs
Chief Financial Officer – Kymera TherapeuticsPierre Jacquet
Managing Director & Partner – L.E.K. Consulting
Brian Johnson
President – MassMEDICRosanna Kapeller
President & CEO – Rome Therapeutics
Ed Kaye, MD
CEO & Director – Stoke TherapeuticsJeb Keiper
CEO – Nimbus Therapeutics
Jason Kelly
CEO – Ginkgo Bio
Richard Kertzman
Managing Director – First Republic BankIya Khalil
Global Head of the AI Innovation Center – Novartis
Eric Kimble
Chief Commercial Officer – Adagio TherapeuticsBjorn Koch
Senior Vice President, Wealth Management – UBS
Adam Koppel
Managing Director – Bain Capital Life Sciences
Joanne Kotz
President & CEO – Jnana Therapeutics
Nerissa Kreher
Chief Medical Offficer – Entrada Therapeutics
Michel Lagarde
Executive Vice President – Thermo Fisher Scientific
Peter Latham
CEO – Latham Biopharma Group
Donna Lavoie
CEO – LavoieHealthScience
Alison Lawton
Special Advisor to the CEO – Kaleido BiosciencesJeff Leerink
CEO – SVB LeerinkJeff Leiden
Executive Chairman – Vertex Pharmaceuticals
Rami Levin
CEO – SanionaMark Levin
Partner – Third Rock Ventures
David Lucchino
CEO – Frequency Therapeutics
Daniel Lynch
Chairman – bluebird bio
Greg Madison
CEO – Melt PharmaceuticalsIvana Magovcevic-Liebisch
President & CEO – Vigil NeuroscienceMichael Maguire
Healthcare Analyst – Putnam Investments
Ankit Mahadevia
CEO – Spero Therapeutics
Hilary Malone
Chief Operating Officer – Valo Health
John Maraganore
CEO – Alnylam
Eddie Martucci
CEO – Akili Interactive
Cynthia Mazareas
Partner – WilmerHale
Katie McCarthy
Managing Director – Halloran Consulting GroupTravis McCready
Executive Director/National Practice Leader – JLLGeoffrey McDonough
President & CEO – Generation Bio
Bill McVicar
Principal Consultant – BioStrat Consulting
David Meek
President & CEO – FerGene
David Meeker
President & CEO – Rhythm Pharmaceuticals
Dave Mello
President – The Richmond Group
David Melville
CEO – The Bowdoin Group
Jill Milne
President & CEO – Catabasis Pharmaceuticals
Jodie Morrison
CEO – Cadent Therapeutics
Cherie Myatt
Owner & Founder – The CM Group
Ted Myles
Chief Financial Officer & Head of Business Operations – Scholar Rock
Marian Nakada
Vice President, Venture Investments – J&J
Amir Nashat
Partner – Polaris Partners
Susan Nemetz
Principal – The NemetzGroup
Allen Nunnally
Chief Business Officer – Voyager Therapeutics
Susan O'Connor
Chief Human Resources Officer – Beam Therapeutics
Mike O'Hara
Partner – Deloitte
Leslie Orne
Senior Partner – Trinity
Douglas Pagan
Chief Financial Officer – Dicerna
Paris Panayiotopoulos
Senior Managing Director – The Blackstone Group
Kush Parmar
Managing Partner – 5AM Ventures
Deval Patrick
Founder & Chairman – TogetherFUND
Richard Paulson
CEO, North America – Ipsen
Peter Pedro
Executive Vice President – Marsh & McLennan Agency
Brian Pereira
CEO – Visterra
Rob Perez
Operating Partner – General AtlanticAdelene Perkins
President & CEO – Infinity Pharmaceuticals
Paula Ragan
CEO & President – X4 Pharmaceuticals
Jigar Raythatha
CEO – Constellation Pharma
Laurence Reid
CEO – Decibel Therapeutics
Jason Rhodes
Partner – Atlas Venture
Rene Russo
CEO – Xilio Therapeutics
Nabiha Saklayen
Co-Founder & CEO – Cellino Biotech
Ian Sanderson
Chief Financial Officer – Boston Pharmaceuticals
Alicia Secor
President & CEO – Atalanta Therapeutics
Eric Shaff
President & CEO – Seres TherapeuticsBill Sibold
Senior Vice President – Sanofi Genzyme
Nancy Simonian
CEO – Syros Pharmaceuticals
Otello Stampacchia
Founder – Omega Funds
Mary Thistle
Special Advisor – Bill & Melinda Gates Medical Research Institute
Frank Thomas
Chief Financial Officer & Chief Business Officer – Orchard TherapeuticsTimothy Thompson
Healthcare Technology Executive
Timothy Thompson
Healthcare Technology ExecutivePraveen Tipirneni
CEO – Morphic Therapeutic
Mike Tomsicek
Chief Financial Officer – CRISPR Therapeutics
Jose Trevejo
Chief Development Officer – Rocket Pharmaceuticals
Samantha Truex
CEO – Quench Bio
Robert Urban
Global Head (Former/Retired) – J&J Innovation
Rajeev Venkayya
President, Global Vaccines Business Unite – Takeda
Shelia Violette
Co-Founder, Chief Scientific Officer & President of Research – Q32 Bio
Joseph Vittiglio
Executive Vice President & General Counsel – AMAG PharmaceuticalsJoe vonRickenbach
Co-Founder & Chairman – Parexel
Michel Vounatsos
CEO – Biogen
Elizabeth Wagner
Chief Operating Officer – Constant Pharmaceuticals
Christoph Westphal
General Partner – Longwood Fund
Leslie Williams
Board Member – Ocular Therapeutix